within Pharmacolibrary.Drugs.ATC.J;

model J01DD12
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 1.6333333333333335e-06,
    adminDuration  = 600,
    adminMass      = 1000 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0002,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.00023999999999999998,
    k12             = 0.037,
    k21             = 0.037
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>J01DD12</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Cefoperazone is a third-generation cephalosporin antibiotic primarily used for the treatment of susceptible bacterial infections, including those of the respiratory tract, urinary tract, skin, soft tissue, and septicemia. It is effective against a wide range of Gram-negative and some Gram-positive bacteria. Although used clinically, its use has declined due to the availability of newer antibiotics, but it remains approved and used in some countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers after single intravenous administration.</p><h4>References</h4><ol><li><p>Craig, WA, &amp; Gerber, AU (1981). Pharmacokinetics of cefoperazone: a review. <i>Drugs</i> 22 Suppl 1 35–45. DOI:<a href=&quot;https://doi.org/10.2165/00003495-198100221-00010&quot;>10.2165/00003495-198100221-00010</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6456890/&quot;>https://pubmed.ncbi.nlm.nih.gov/6456890</a></p></li><li><p>Montesissa, C, et al., &amp; Carli, S (2003). Pharmacodynamics and pharmacokinetics of cefoperazone and cefamandole in dogs following single dose intravenous and intramuscular administration. <i>Veterinary journal (London, England : 1997)</i> 166(2) 170–176. DOI:<a href=&quot;https://doi.org/10.1016/s1090-0233(03)00051-0&quot;>10.1016/s1090-0233(03)00051-0</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/12902182/&quot;>https://pubmed.ncbi.nlm.nih.gov/12902182</a></p></li><li><p>Bosso, JA, et al., &amp; Matsen, JM (1983). Cefoperazone pharmacokinetics in preterm infants. <i>Antimicrobial agents and chemotherapy</i> 23(3) 413–415. DOI:<a href=&quot;https://doi.org/10.1128/AAC.23.3.413&quot;>10.1128/AAC.23.3.413</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6221693/&quot;>https://pubmed.ncbi.nlm.nih.gov/6221693</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end J01DD12;
